Trilogy Capital Inc. Danaher Corp Transaction History
Trilogy Capital Inc.
- $1.92 Billion
- Q3 2024
A detailed history of Trilogy Capital Inc. transactions in Danaher Corp stock. As of the latest transaction made, Trilogy Capital Inc. holds 1,480 shares of DHR stock, worth $341,140. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,480
Previous 1,499
1.27%
Holding current value
$341,140
Previous $374,000
9.89%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding DHR
# of Institutions
2,509Shares Held
542MCall Options Held
7.07MPut Options Held
4.55M-
Vanguard Group Inc Valley Forge, PA59.4MShares$13.7 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY50.5MShares$11.6 Billion0.29% of portfolio
-
State Street Corp Boston, MA27.5MShares$6.33 Billion0.32% of portfolio
-
Wellington Management Group LLP Boston, MA23.3MShares$5.37 Billion1.16% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD20.5MShares$4.72 Billion0.66% of portfolio
About DANAHER CORP
- Ticker DHR
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 727,963,008
- Market Cap $168B
- Description
- Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...